Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.46 USD | +2.27% | -7.88% | -2.98% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.98% | 430M | |
+48.78% | 57.87B | |
+41.65% | 40.25B | |
-7.35% | 39.94B | |
-5.96% | 28.54B | |
+12.45% | 26.4B | |
-20.06% | 19.33B | |
+30.25% | 12.4B | |
-0.53% | 12.23B | |
+24.78% | 12.2B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- HC Wainwright Adjusts Korro Bio's Price Target to $115 From $100, Buy Rating Kept